The committee will be asked to consider a variety of topics including identifying the effects of the alteration of the nicotine yields from [image-nocss] tobacco products; reporting on the impact of the use of menthol in cigarettes on the public health; and advising on an application for modified risk (use of descriptors such as "light") tobacco product.
The TPSAC will consist of 12 members, including the chair to be selected by the Commissioner of Food & Drugs, from among experts knowledgeable in the fields of medicine, medical ethics, science or technology involving the manufacture, evaluation or use of tobacco products. There will be nine voting and three nonvoting members. Of the nine voting members, seven will be health care professionals practicing in the area of oncology, pulmonology, cardiology, toxicology, pharmacology, addiction or any other relevant specialty. One member will be an officer or employee of a state or local government or the federal government and the final member will be a representative of the general public.
The three nonvoting members will be identified with industry interests. These members will include one representative of the tobacco manufacturing industry, one representative of the tobacco growers and one representative of the small-business manufacturing industry.
Three related Federal Register documents are on display and being published; one announces the establishment of the new advisory committee, one requests nominations for voting members to serve on the committee, and one requests nominations for non-voting members. Click here for more information.
Members help make our journalism possible. Become a CSP member today and unlock exclusive benefits, including unlimited access to all of our content. Sign up here.